Actemra 160mg, a treatment known scientifically as tocilizumab, represents a potent biologic agent primarily employed for the management of rheumatoid arthritis. This powerful agent functions by blocking the activity of interleukin-6 (IL-6), a signaling protein essential in the inflammatory process. Furthermore, Actemra exhibits efficacy in the ma